Skip to main content
SpringerLink
Log in

Comment on “Effect of Age-Related Factors on the Pharmacokinetics of Lamotrigine and Potential Implications for Maintenance Dose Optimisation in Future Clinical Trials”

  • Letter to the Editor
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

A Letter to the Editor to this article was published on 20 July 2018

The Original Article was published on 23 January 2018

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. van Dijkman SC, de Jager NCB, Rauwe WM, Danhof M, Della Pasqua O. Effect of age-related factors on the pharmacokinetics of lamotrigine and potential implications for maintenance dose optimisation in future clinical trials. Clin Pharmacokinet. 2018. https://doi.org/10.1007/s40262-017-0614-5.

    Article  PubMed  Google Scholar 

  2. van Dijkman SC, de Jager NCB, Rauwe WM, Danhof M, Della Pasqua O. Correction to: effect of age-related factors on the pharmacokinetics of lamotrigine and potential implications for maintenance dose optimisation in future clinical trials. Clin Pharmacokinet. 2018. https://doi.org/10.1007/s40262-018-0660-7.

    Article  PubMed  Google Scholar 

  3. Sumpter AL, Holford NH. Predicting weight using postmenstrual age—neonates to adults. Paediatr Anaesth. 2011;21:309–15.

    Article  PubMed  Google Scholar 

  4. Wang C, Peeters MY, Allegaert K, Blussé van Oud-Alblas HJ, Krekels EH, Tibboel D, et al. A bodyweight-dependent allometric exponent for scaling clearance across the human life-span. Pharm Res. 2012;29:1570–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Lonsdale DO, Kipper K, Barker C, Johnston A, Philips B, Rhodes A, et al. Standard beta–lactam doses fail to achieve PK/PD targets in critically ill patients of all ages, with children particularly at risk: results from the ABDose study [poster no. O0808]. 28th ECCMID (European Congress of Clinical Microbiology and Infectious Diseases) Meeting; 21–24 Apr 2018; Madrid.

  6. Hennig S, Standing JF, Staatz CE, Thomson AH. Population pharmacokinetics of tobramycin in patients with and without cystic fibrosis. Clin Pharmacokinet. 2013;52:289–301.

    Article  CAS  PubMed  Google Scholar 

  7. McCune JS, Bemer MJ, Barrett JS, Scott Baker K, Gamis AS, Holford NH. Busulfan in infant to adult hematopoietic cell transplant recipients: a population pharmacokinetic model for initial and Bayesian dose personalization. Clin Cancer Res. 2014;20:754–63.

    Article  CAS  PubMed  Google Scholar 

  8. Holford NH, Ma SC, Anderson BJ. Prediction of morphine dose in humans. Paediatr Anaesth. 2012;22:209–22.

    Article  PubMed  Google Scholar 

  9. Calvier EA, Krekels EH, Välitalo PA, Rostami-Hodjegan A, Tibboel D, Danhof M, et al. Allometric scaling of clearance in paediatric patients: when does the magic of 0.75 fade? Clin Pharmacokinet. 2017;56:273–85.

    Article  PubMed  Google Scholar 

  10. Holford N, Heo YA, Anderson B. A pharmacokinetic standard for babies and adults. J Pharm Sci. 2013;102:2941–52.

    Article  CAS  PubMed  Google Scholar 

  11. Germovsek E, Barker CI, Sharland M, Standing JF. Scaling clearance in paediatric pharmacokinetics: all models are wrong, which are useful? Br J Clin Pharmacol. 2017;83:777–90.

    Article  CAS  PubMed  Google Scholar 

  12. Polepally AR, Remmel RP, Brundage RC, Leppik IE, Rarick JO, Ramsay RE, et al. Steady-state pharmacokinetics and bioavailability of immediate-release and extended-release formulations of lamotrigine in elderly epilepsy patients: use of stable isotope methodology. J Clin Pharmacol. 2015;55:1101–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. UCL Great Ormond Street Institute for Child Health, Room 661, London, WC1N 1EH, UK

    Joseph F. Standing

  2. Department of Anaesthesia, University of Auckland, Auckland, New Zealand

    Brian J. Anderson

  3. School of Pharmacy, The University of Queensland, Brisbane, QLD, Australia

    Stefanie Hennig

  4. Department of Pharmacology and Clinical Pharmacology, University of Auckland, Auckland, New Zealand

    Nick H. Holford

  5. Certara UK Limited, Simcyp Division, Sheffield, UK

    Trevor N. Johnston

  6. Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, University of Leiden, Leiden, The Netherlands

    Catherijne A. J. Knibbe

  7. Department of Clinical Pharmacology, Institute for Infection and Immunity, St George’s University of London, London, UK

    Dagan O. Lonsdale

  8. Centre for Applied Pharmacokinetic Research (CAPKR), University of Manchester, Manchester, UK

    Amin Rostami-Hodjegan

Authors
  1. Joseph F. Standing
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Brian J. Anderson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stefanie Hennig
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nick H. Holford
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Trevor N. Johnston
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Catherijne A. J. Knibbe
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Dagan O. Lonsdale
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Amin Rostami-Hodjegan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joseph F. Standing.

Ethics declarations

Funding

No external funding was used in the preparation of this letter.

Conflict of interest

Joseph F. Standing, Brian J. Anderson, Stefanie Hennig, Nick H. Holford, Trevor Johnston, Catherjine A.J. Knibbe, Dagan O. Lonsdale and Amin Rostami-Hodjegan declare that they have no conflicts of interest that might be relevant to the contents of this letter.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Standing, J.F., Anderson, B.J., Hennig, S. et al. Comment on “Effect of Age-Related Factors on the Pharmacokinetics of Lamotrigine and Potential Implications for Maintenance Dose Optimisation in Future Clinical Trials”. Clin Pharmacokinet 57, 1471–1472 (2018). https://doi.org/10.1007/s40262-018-0697-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40262-018-0697-7

Search

Navigation